[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:immunodeficiency":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":117,"states":118},"Immunodeficiency",17,16,[8,16,23,29,36,43,50,56,62,68,74,80,86,92,98,104,110],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT03808922","Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study",[12],"Phase 3","RECRUITING","2026-08-26T02:18:04.640417Z","2026-05-05T02:43:29.671541Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT01861106","Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations",[20],"Phase 2","2026-08-26T02:15:18.897219Z","2026-05-05T02:43:29.057566Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT01666080","Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)",[],"2026-08-26T02:19:02.550788Z","2026-05-05T02:43:28.871503Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":34,"content_modified":35},"NCT02356653","Expanded Access Protocol Using CD3+\u002FCD19+ Depleted PBSC",[33],"Early Phase 1","2026-08-26T02:16:08.402952Z","2026-05-05T02:43:29.132129Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":41,"content_modified":42},"NCT06839456","Phase 1\u002F2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab\u002FCD19 Depleted HSCT",[40],"Phase 1\u002FPhase 2","2026-08-26T02:18:26.932189Z","2026-05-05T02:43:28.655842Z",{"nct_id":44,"title":45,"phases":46,"status":13,"updated_at":48,"content_modified":49},"NCT06926894","R-MVST Cells for Treatment of Viral Infections in Children and Young Adults",[47],"Phase 1","2026-08-26T02:17:53.433613Z","2026-05-05T02:43:27.623199Z",{"nct_id":51,"title":52,"phases":53,"status":13,"updated_at":54,"content_modified":55},"NCT00001355","Detection and Characterization of Host Defense Defects",[],"2026-08-26T02:18:55.570428Z","2026-07-05T18:42:10.719647Z",{"nct_id":57,"title":58,"phases":59,"status":13,"updated_at":60,"content_modified":61},"NCT01212055","Apheresis of Patients With Immunodeficiency",[],"2026-08-26T02:16:56.877406Z","2026-05-13T02:55:06.069841Z",{"nct_id":63,"title":64,"phases":65,"status":13,"updated_at":66,"content_modified":67},"NCT05584488","Allergy and Immunology Natural History Study",[],"2026-08-26T02:16:14.341106Z","2026-05-13T02:55:06.364273Z",{"nct_id":69,"title":70,"phases":71,"status":13,"updated_at":72,"content_modified":73},"NCT04784364","Biologics And Clinical Immunology Cohort at Sinai",[],"2026-08-26T02:17:23.750999Z","2026-05-13T02:55:06.268652Z",{"nct_id":75,"title":76,"phases":77,"status":13,"updated_at":78,"content_modified":79},"NCT03300830","Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease",[],"2026-08-26T02:19:08.862440Z","2026-05-13T02:55:06.121750Z",{"nct_id":81,"title":82,"phases":83,"status":13,"updated_at":84,"content_modified":85},"NCT03016806","Umbilical Cord Blood Transplantation From Unrelated Donors",[],"2026-08-26T02:15:21.365312Z","2026-05-13T02:55:06.119599Z",{"nct_id":87,"title":88,"phases":89,"status":13,"updated_at":90,"content_modified":91},"NCT02417740","Natural History of Noncirrhotic Portal Hypertension",[],"2026-08-26T02:17:04.346841Z","2026-05-13T02:55:06.096931Z",{"nct_id":93,"title":94,"phases":95,"status":13,"updated_at":96,"content_modified":97},"NCT01890486","The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen",[],"2026-08-26T02:18:22.309547Z","2026-05-13T02:55:06.079164Z",{"nct_id":99,"title":100,"phases":101,"status":13,"updated_at":102,"content_modified":103},"NCT00128973","Evaluation of Patients With Immune Function Abnormalities",[],"2026-08-26T02:16:54.876240Z","2026-05-13T02:55:06.032743Z",{"nct_id":105,"title":106,"phases":107,"status":13,"updated_at":108,"content_modified":109},"NCT06689800","Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy",[],"2026-08-26T02:19:29.119921Z","2026-05-05T02:43:28.852930Z",{"nct_id":111,"title":112,"phases":113,"status":114,"updated_at":115,"content_modified":116},"NCT07670156","Upadacitinib in Treatment of JAK\u002FSTAT Pathway Disorders With Activating Mutations",[40],"NOT_YET_RECRUITING","2026-08-26T02:18:16.220328Z","2026-07-05T03:45:20.371272Z",[],[119,123,127,131],{"state":120,"count":121,"slug":122},"Maryland",7,"maryland",{"state":124,"count":125,"slug":126},"New York",6,"new-york",{"state":128,"count":129,"slug":130},"Missouri",3,"missouri",{"state":132,"count":129,"slug":133},"Pennsylvania","pennsylvania"]